Sort   by:  
 Page size 
UnknownLenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.
Not available
S-EPMC4123422 | biostudies-literature
UnknownBlockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.
Not available
S-EPMC1852228 | biostudies-literature
UnknownFunctional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).
Not available
S-EPMC2965086 | biostudies-literature
UnknownMicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
Not available
S-EPMC2265455 | biostudies-literature
UnknownPreclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
Not available
S-EPMC4714665 | biostudies-literature
UnknownFZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.
Not available
S-EPMC5383867 | biostudies-literature
UnknownAtg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.
Not available
S-EPMC5009514 | biostudies-literature
UnknownSingle cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Not available
S-EPMC8524723 | biostudies-literature
UnknownEpigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures.
Not available
S-EPMC9949063 | biostudies-literature
UnknownImplications of the miR-10 family in chemotherapy response of NPM1-mutated AML.
Not available
S-EPMC3983615 | biostudies-literature
Sort   by:  
 Page size